Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease demyelinating disease
Phenotype C0035435|rheumatic disease
Sentences 2
PubMedID- 22152489 Objectives: to estimate the rate of demyelinating diseases in patients with rheumatic diseases treated with tumor necrosis factor (tnf) antagonists and to describe the cases reported to 3 different pharmacovigilance sources.
PubMedID- 20864146 The incidence rate of demyelinating disease in patients with rheumatic diseases exposed to tnf antagonists in biobadaser was 0.65 per 1000 patient-years (95%ci: 0.39-1.1).

Page: 1